Standardisation of metalloimmunoassay protocols for assessment of silver nanoparticle antibody conjugates

Journal of Immunological Methods

Volumn 387, Issue 1-2, 2013, Pages 303-307

  Wilson, P K ^a   Szymanski, M ^a   Porter, R ^a  

^a NATIONAL PHYSICAL LABORATORY   (United Kingdom)

Author keywords

Cardiac markers; Immunoassay; Metalloimmunoassay; Point of care diagnostics; Silver nanoparticles; Troponin

Indexed keywords

ANTIBODY CONJUGATE; SILVER NANOPARTICLE; THIOCYANIC ACID DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; ELECTROCHEMISTRY; IMMUNOASSAY; INCUBATION TIME; METALLOIMMUNOASSAY; PH; PRIORITY JOURNAL; STANDARDIZATION;

ANTIBODIES; ANTIBODIES, IMMOBILIZED; BUFFERS; ELECTROCHEMICAL TECHNIQUES; HYDROGEN-ION CONCENTRATION; IMMUNOASSAY; METAL NANOPARTICLES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SILVER; THIOCYANATES; TIME FACTORS;

EID: 84871406783     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.08.001     Document Type: Article

References (12)

1. Alpert J.S., Thygesen K., Jaffe A., White H.D. Ischaemic heart disease - the universal definition of myocardial infarction: a consensus document. Heart 2008, 94:1335.
2. Burtonwood C., Halloran S. Three Point of Care Devices for Troponin Measurement, National Health Service Evaluation Report 06020 2006.
3. Campbell F.W., Compton R.G. The use of nanoparticles in electroanalysis: an updated review. Anal. Bioanal. Chem. 2010, 396:241.
4. Dequaire M., Degrand C., Limoges B. An electrochemical metalloimmunoassay based on a colloidal gold label. Anal. Chem. 2000, 72:5521.
5. Eggers K.M., Oldgren J., Nordenskjold A., Lindahl B. Combining different biochemical markers of myocardial ischemia does not improve risk stratification in chest pain patients compared to troponin I alone. Coron. Artery Dis. 2005, 16:315.
6. Jans H., Liu X., Austin L., Maes G., Huo Q. Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding studies. Anal. Chem. 2009, 81:9425.
7. Morrow D.A., Antman E.M. Evaluation of high-sensitivity assays for cardiac troponin. Clin. Chem. 2009, 55:5.
8. Porter R., Kabil A., Forstern C., Slevin C., Kouwenberg K., Szymanski M., Birch B. A novel, generic, electroanalytical immunoassay format utilising silver nano-particles as a bio-label. J. Immunoass. Immunochem. 2009, 30:428.
9. Panteghini M., Bunk D.M., Christenson R.H., Katrukha, Porter R.A., Schimmel H., Wang L., Tate J.R. Standardization of troponin I measurements: an update. Clin. Chem. Lab. Med. 2008, 46:1501.
10. Schreiber D.H., Miller S.M. Use of Cardiac Markers in the Emergency Department. eMedicine Medscape Article 811905 2009, (URL http://www.emedicine.medscape.com/article/811905-overview Accessed: 04 Mar 2010).
11. Szymanski M., Turner A.P.F., Porter R. Electrochemical dissolution of silver nanoparticles and its application in metalloimmunoassay. Electroanalysis 2009, 22:191.
12. von Lode P. Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. Clin. Biochem. 2005, 38:591.